Search results for "Nifurtimox"

showing 4 items of 4 documents

Antiparasitic Effect of Stilbene and Terphenyl Compounds against Trypanosoma cruzi Parasites

2021

AbstractBackgroundChagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite Trypanosoma cruzi. No progress in the treatment of this pathology has been made since Nifurtimox was introduced more than fifty years ago and is considered very aggressive and may cause several adverse effects. Currently, this drug has severe limitations, including high frequency of undesirable side effects and limited efficacy and availability and the research to discover new drugs for the treatment of Chagas disease is imperative. Many drugs available in the market are natural products as found in nature or compounds designed based on the str…

Chagas diseaseAntiparasiticmedicine.drug_classTrypanosoma cruzi<i>Trypanosoma cruzi</i>Pharmaceutical ScienceParasitemiaPharmacologyTrypanosoma cruzi.Pharmacy and materia medicaDrug DiscoverymedicineCytotoxic T cellStilbene ST18NifurtimoxAmastigoteTrypanosoma cruzibiologyChemistryR<i>Trypanosoma cruzi</i>; stilbene ST18; terphenyl TR4biology.organism_classificationmedicine.diseaseRS1-441TrypanosomaMedicineMolecular MedicineTerphenyl TR4medicine.drugPharmaceuticals
researchProduct

Identification &lt;i&gt;In Silico&lt;/i&gt; and &lt;i&gt;In Vitro&lt;/i&gt; of Novel Trypanosomicidal Drug-like Compounds

2012

Atom-based bilinear indices and linear discriminant analysis are used to discover novel trypanosomicidal compounds. The obtained linear discriminant analysis-based quantitative structure–activity relationship models, using non-stochastic and stochastic indices, provide accuracies of 89.02% (85.11%) and 89.60% (88.30%) of the chemicals in the training (test) sets, respectively. Later, both models were applied to the virtual screening of 18 in-house synthesized compounds to find new pro-lead antitrypanosomal agents. The in vitro antitrypanosomal activity of this set against epimastigote forms of Trypanosoma cruzi is assayed. Predictions agree with experimental results to a great extent (16/18…

DrugVirtual screeningChromatographybiologyChemistrymedia_common.quotation_subjectIn silicobiology.organism_classificationLinear discriminant analysisIn vitromedicineTrypanosoma cruziNifurtimoxmedia_commonmedicine.drugProceedings of The 16th International Electronic Conference on Synthetic Organic Chemistry
researchProduct

Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichag…

2012

Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3- ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22-32, 34-38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low un…

Models MolecularDrugChagas diseaseIndazolesStereochemistryTrypanosoma cruzimedia_common.quotation_subjectStructure-Activity Relationshipchemistry.chemical_compoundParasitic Sensitivity TestsDrug DiscoverymedicineNifurtimoxTrypanosoma cruziBiological evaluationmedia_commonPharmacologyIndazoleDose-Response Relationship DrugMolecular StructurebiologyOrganic ChemistryGeneral Medicinemedicine.diseasebiology.organism_classificationTrypanocidal AgentsCombinatorial chemistrychemistryBenznidazolemedicine.drugEuropean Journal of Medicinal Chemistry
researchProduct

Identification In Silico and In Vitro of Novel Trypanosomicidal Drug-Like Compounds

2012

Atom-based bilinear indices and linear discriminant analysis are used to discover novel trypanosomicidal compounds. The obtained linear discriminant analysis-based quantitative structure–activity relationship models, using non-stochastic and stochastic indices, provide accuracies of 89.02% (85.11%) and 89.60% (88.30%) of the chemicals in the training (test) sets, respectively. Later, both models were applied to the virtual screening of 18 in-house synthesized compounds to find new pro-lead antitrypanosomal agents. The in vitro antitrypanosomal activity of this set against epimastigote forms of Trypanosoma cruzi is assayed. Predictions agree with experimental results to a great extent (16/18…

PharmacologyDrugVirtual screeningbiologyStereochemistryIn silicomedia_common.quotation_subjectOrganic ChemistryLinear discriminant analysisbiology.organism_classificationBiochemistryIn vitroDrug DiscoverymedicineMolecular MedicineNifurtimoxTrypanosoma cruzimedicine.drugmedia_commonChemical Biology &amp; Drug Design
researchProduct